AbbVie
The 2027 Drug Substance Engineering Intern (PhD) role at AbbVie offers a summer internship focused on optimizing drug substance micronization processes. The intern will work within the Product Development, Science, and Technology (PDS&T) department to study how powder properties affect feeding performance in micronization techniques. This position provides world-class experience in a dynamic pharmaceutical organization, collaborating with energetic colleagues and inspirational leaders.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
2027 Summer Intern PhD Student - Drug Product Development Material Characterization
Bristol Myers Squibb
2027 Summer Intern PhD Student - Drug Product Development Engineering
Bristol Myers Squibb
Drug Development Materials Science Associate
Eurofins
Drug Development Materials Science Associate
Eurofins
Drug Development Materials Science Associate
Eurofins
Powder Characterization Scientist
Eurofins